<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02287168</url>
  </required_header>
  <id_info>
    <org_study_id>GastCancPerLav2014</org_study_id>
    <nct_id>NCT02287168</nct_id>
  </id_info>
  <brief_title>Effect of Peritoneal Lavage on Surgery-induced Positive Peritoneal Cytology in Gastric Cancer Patients</brief_title>
  <official_title>Effect of Peritoneal Lavage on Surgery-induced Positive Peritoneal Cytology in Gastric Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bezmialem Vakif University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bezmialem Vakif University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgical manipulation and handling of a tumor may cause dissemination of cancer cells through
      peritoneal cavity after curative gastrectomy. Intra operative peritoneal lavage may have
      preventive effect on positive peritoneal cytology occurred during gastrectomy in patients
      with gastric cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Peritoneal dissemination of gastric adenocarcinoma cells is the most frequent cause of death
      in patients with gastric cancer. Spreading of these cells occur by three routes: direct
      seeding via infiltration through gastric wall, via blood vessels and via perigastric
      lymphatic channels disturbed during lymph node dissection. Conversion of negative
      preoperative peritoneal cytology to positive cytology after curative gastrectomy has been
      shown by previous studies.

      Although extensive intra-operative peritoneal lavage (1 L of physiologic saline 10 times) has
      been shown to be an effective method to eliminate cancer cell dissemination during surgery,
      to cause significant improvement in survival after gastrectomy, widespread use of this
      approach has not existed most probably due to its time consuming technical difficulty.
      Therefore,intra-operative peritoneal lavage (1 L of physiologic saline 3 times) may be used
      more frequently during gastric surgery.If it is possible to show effectivity of
      intra-operative peritoneal lavage using a total of 3 L physiologic saline to eliminate cancer
      cell dissemination occurred before or after gastric surgery, use of this approach may gain
      acceptance to decrease risk of peritoneal metastasis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>elimination</measure>
    <time_frame>at the operation</time_frame>
    <description>rate of conversion of positive cytology results to negative cytology by peritoneal lavage during the surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>dissemination</measure>
    <time_frame>at the operation</time_frame>
    <description>rate of conversion of negative cytology results to positive cytology by surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Gastric Adenocarcinoma</condition>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>dissemination of cancer cells</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>conversion of negative result of pre-gastrectomy peritoneal washing cytology to positive cytology after gastrectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>elimination of cancer cells</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>elimination of peritoneal cancer cells occurred before (pre-gastrectomy peritoneal washing cytology) or after gastrectomy (post-gastrectomy peritoneal washing cytology) by intra operative peritoneal lavage ('post-lavage peritoneal washing cytology)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pre-gastrectomy peritoneal washing cytology</intervention_name>
    <description>sampling of peritoneal washing fluid before gastrectomy</description>
    <arm_group_label>dissemination of cancer cells</arm_group_label>
    <arm_group_label>elimination of cancer cells</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>post-gastrectomy peritoneal washing cytology</intervention_name>
    <description>sampling of peritoneal washing fluid after gastrectomy</description>
    <arm_group_label>dissemination of cancer cells</arm_group_label>
    <arm_group_label>elimination of cancer cells</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>post-lavage peritoneal washing cytology</intervention_name>
    <description>sampling of peritoneal washing fluid after peritoneal lavage</description>
    <arm_group_label>elimination of cancer cells</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Endoscopically proven gastric adenocarcinoma

          -  Standard gastrectomy and a D2 lymph node dissection;

          -  Desire to attend the study protocol

        Exclusion Criteria:

          -  Metastatic or overt peritoneal disseminated cancer

          -  Undesired reaction to attend the study protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bezmialem Vakif University Faculty of Medicine Dept of General Surgery</name>
      <address>
        <city>Istanbul</city>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mustafa Hasbahceci</name>
      <address>
        <city>Istanbul</city>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Yu XF, Ren ZG, Xue YW, Song HT, Wei YZ, Li CM. D2 lymphadenectomy can disseminate tumor cells into peritoneal cavity in patients with advanced gastric cancer. Neoplasma. 2013;60(2):174-81.</citation>
    <PMID>23259786</PMID>
  </reference>
  <reference>
    <citation>Shimada S, Kuramoto M, Marutsuka T, Yagi Y, Baba H. Adopting extensive intra-operative peritoneal lavage (EIPL) as the standard prophylactic strategy for peritoneal recurrence. Rev Recent Clin Trials. 2011 Sep;6(3):266-70.</citation>
    <PMID>21682671</PMID>
  </reference>
  <reference>
    <citation>Yamamoto K, Shimada S, Hirota M, Yagi Y, Matsuda M, Baba H. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer. Int J Oncol. 2005 Nov;27(5):1321-8.</citation>
    <PMID>16211228</PMID>
  </reference>
  <reference>
    <citation>Misawa K, Mochizuki Y, Ohashi N, Matsui T, Nakayama H, Tsuboi K, Sakai M, Ito S, Morita S, Kodera Y. A randomized phase III trial exploring the prognostic value of extensive intraoperative peritoneal lavage in addition to standard treatment for resectable advanced gastric cancer: CCOG 1102 study. Jpn J Clin Oncol. 2014 Jan;44(1):101-3. doi: 10.1093/jjco/hyt157. Epub 2013 Nov 27.</citation>
    <PMID>24287077</PMID>
  </reference>
  <reference>
    <citation>Kuramoto M, Shimada S, Ikeshima S, Matsuo A, Yagi Y, Matsuda M, Yonemura Y, Baba H. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg. 2009 Aug;250(2):242-6. doi: 10.1097/SLA.0b013e3181b0c80e.</citation>
    <PMID>19638909</PMID>
  </reference>
  <reference>
    <citation>Marutsuka T, Shimada S, Shiomori K, Hayashi N, Yagi Y, Yamane T, Ogawa M. Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis. Clin Cancer Res. 2003 Feb;9(2):678-85.</citation>
    <PMID>12576435</PMID>
  </reference>
  <reference>
    <citation>Shimada S, Tanaka E, Marutsuka T, Honmyo U, Tokunaga H, Yagi Y, Aoki N, Ogawa M. Extensive intraoperative peritoneal lavage and chemotherapy for gastric cancer patients with peritoneal free cancer cells. Gastric Cancer. 2002;5(3):168-72.</citation>
    <PMID>12378344</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2014</study_first_submitted>
  <study_first_submitted_qc>November 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2014</study_first_posted>
  <last_update_submitted>March 26, 2016</last_update_submitted>
  <last_update_submitted_qc>March 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bezmialem Vakif University</investigator_affiliation>
    <investigator_full_name>Mustafa Hasbahceci</investigator_full_name>
    <investigator_title>MD, general surgeon</investigator_title>
  </responsible_party>
  <keyword>Peritoneal lavage</keyword>
  <keyword>Dissemination</keyword>
  <keyword>Gastrectomy</keyword>
  <keyword>Cytology</keyword>
  <keyword>Lavage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

